GBp 0.6
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 794.8 Thousand USD | -56.09% |
2022 | 1.8 Million USD | 40.52% |
2021 | 1.28 Million USD | 108.01% |
2020 | 619.2 Thousand USD | -47.91% |
2019 | 1.18 Million USD | 0.0% |
2017 | 1.78 Million USD | 41.81% |
2016 | 1.25 Million USD | 247.59% |
2015 | 362.36 Thousand USD | -57.46% |
2014 | 851.84 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | 794.8 Thousand USD | 3.81% |
2023 Q4 | 794.8 Thousand USD | 0.0% |
2023 Q2 | 765.61 Thousand USD | 0.0% |
2023 Q1 | 765.61 Thousand USD | -57.7% |
2023 FY | 794.8 Thousand USD | -56.09% |
2022 Q4 | 1.8 Million USD | 0.0% |
2022 FY | 1.8 Million USD | 40.52% |
2022 Q1 | 1.65 Million USD | 28.46% |
2022 Q2 | 1.65 Million USD | 0.0% |
2022 Q3 | 1.8 Million USD | 9.39% |
2021 Q1 | 808.27 Thousand USD | 30.53% |
2021 Q4 | 1.28 Million USD | 0.0% |
2021 Q3 | 1.28 Million USD | 59.36% |
2021 Q2 | 808.27 Thousand USD | 0.0% |
2021 FY | 1.28 Million USD | 108.01% |
2020 Q1 | 713.47 Thousand USD | 0.0% |
2020 Q2 | 713.47 Thousand USD | 0.0% |
2020 Q3 | 619.2 Thousand USD | -13.21% |
2020 Q4 | 619.2 Thousand USD | 0.0% |
2020 FY | 619.2 Thousand USD | -47.91% |
2019 Q2 | 1.66 Million USD | 0.0% |
2019 Q1 | 1.66 Million USD | 0.0% |
2019 FY | 1.18 Million USD | 0.0% |
2018 Q2 | 1.78 Million USD | 1.37% |
2018 Q1 | 1.76 Million USD | -9.94% |
2017 Q3 | 1.95 Million USD | 55.32% |
2017 Q1 | 1.37 Million USD | 32.21% |
2017 FY | 1.78 Million USD | 41.81% |
2017 Q4 | 1.95 Million USD | 0.0% |
2017 Q2 | 1.25 Million USD | -8.34% |
2016 Q1 | 362.36 Thousand USD | 0.0% |
2016 FY | 1.25 Million USD | 247.59% |
2016 Q2 | 362.36 Thousand USD | 0.0% |
2016 Q4 | 1.03 Million USD | 0.0% |
2016 Q3 | 1.03 Million USD | 186.82% |
2015 Q2 | 851.84 Thousand USD | 0.0% |
2015 FY | 362.36 Thousand USD | -57.46% |
2015 Q1 | 851.84 Thousand USD | 0.0% |
2015 Q3 | - USD | -100.0% |
2014 FY | 851.84 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|